RudaCure, a bio-venture company developing tratamientos for intractable diseases, held a transferencia de tecnología acuerdo signing ceremonia with Hanlim Pharmaceutical Co., Ltd., a mid-sized company developing nacional enfermedad oftálmica tratamientos, on the 13th for the úlcera corneal and daño corneal tratamiento RCI001U.
RCI001U is a pipeline derived from the existing tratamiento de la enfermedad de ojo seco RCI001, and has demostró superior daño corneal healing effects compared to existing corneal tratamientos. A través de esto acuerdo, RudaCure provides Hanlim Pharmaceutical with nacional producción and sales rights to the tecnología and receives pagos por hitos including ensayo clínico aprobacións.
Given the current absence of nacional drugs for daño corneal tratamiento, RudaCure's RCI001U is being transferred after completing third-party confirmatory eficacia testing along with non-clinical toxicology studies. It is esperado that RudaCure and its strategic partner Hanlim Pharmaceutical will be able to respond swiftly to the daño corneal tratamiento mercado where drugs are currently absent.
RudaCure had already completó the nacional transferencia de tecnología of the tratamiento de la enfermedad de ojo seco RCI001 to Hanlim Pharmaceutical in April 2021, and by executing this additional indication desarrollo acuerdo, the network between the two empresas ha sido further fortaleció. En el futuro, it is esperado that continuous colaboración will be pursued not only for enfermedad de ojo seco and daño corneal tratamientos, but also for the desarrollo of various oftálmico tratamientos including ocular implants for macular degeneration tratamiento.
메디팜헬스 http://www.medipharmhealth.co.kr/news/article.html?no=88169 헬스코리아 뉴스 https://www.hkn24.com/news/articleView.html?idxno=331344 메디파나 https://www.medipana.com/article/view.php?news_idx=307266&sch_cate=D팜뉴스 https://www.pharmnews.com/news/articleView.html?idxno=217143
헤럴드경제 http://news.heraldcorp.com/view.php?ud=20230116000105
메디소비자뉴스 http://www.medisobizanews.com/news/articleView.html?idxno=103851
데일리팜 http://www.dailypharm.com/Users/News/NewsView.html?ID=296092
약업신문 https://www.yakup.com/news/index.html?mode=view&cat=12&nid=277798
